Image de couverture de livre

Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Fleur Veldman, Christopher J. Black, Andrea Shin, Daniel Keszthelyi
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	British Journal of Pharmacology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

S1P/S1PRs‐TRPV4 axis is a novel therapeutic target for persistent pain and itch in chronic dermatitis
par: Xinyu Zhang, et autres
Publié: (2024)

Glial modulators as novel therapeutics for comorbid pain and opioid use disorder
par: Elizabeth K. C. Schwartz, et autres
Publié: (2024)

Low‐dose amitriptyline: A potential therapeutic option for chronic pain in older people
par: Takayuki Suga, et autres
Publié: (2024)

Psilocybin as a novel treatment for chronic pain
par: Tate Askey, et autres
Publié: (2024)

Novel approaches for drug development against chronic primary pain: A systematic review
par: Valéria Tékus, et autres
Publié: (2025)

Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders
par: Eduardo Rivera‐Mancilla, et autres
Publié: (2025)

Recent innovations in targeting redox biology for therapeutics
par: Miriam M. Cortese‐Krott, et autres
Publié: (2025)

Cancer pain: current practice and emerging targets
par: Yi Ye, et autres
Publié: (2026)

Editorial for the themed issue: Addressing the dual challenges of opioid use disorder and chronic pain in the context of the opioid crisis
par: Mehmet Sofuoglu, et autres
Publié: (2024)

Bioactive ligands targeting ectopic olfactory receptors: Implications for therapeutic strategies
par: Hui Zhao, et autres
Publié: (2025)

Cathepsins: Novel opportunities for antibody therapeutics in cancer
par: Timothée David, et autres
Publié: (2025)

The cytoplasmic sensor, the AIM2 inflammasome: A precise therapeutic target in vascular and metabolic diseases
par: Jiuguo Lin, et autres
Publié: (2024)

Pathway‐level mutational signatures predict breast cancer outcomes and reveal therapeutic targets
par: Máté Posta, et autres
Publié: (2025)

An antisense oligonucleotide targeting the heat‐shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis
par: Pierre‐Marie Boutanquoi, et autres
Publié: (2025)

The association of pain impact and sleep disruption with opioid withdrawal during opioid‐use disorder treatment
par: Jennifer D. Ellis, et autres
Publié: (2024)

PPARγ is a potential therapeutic target for radiation enteritis via suppressing ferroptosis, mediated by the GAPDH/glycosylation axis
par: Xi Zeng, et autres
Publié: (2025)

Correction to An antisense oligonucleotide targeting the heat‐shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis
Publié: (2025)

Intravenous recombinant cerebellin 1 treatment restores signalling by spinal glutamate delta 1 receptors and mitigates chronic pain
par: Siddhesh S. Sabnis, et autres
Publié: (2024)

Monocytic microRNAs—Novel targets in atherosclerosis therapy
par: Gerhild Euler, et autres
Publié: (2024)

Activation of peripheral cannabinoid receptors by CB13 attenuates burn injury–induced chronic pain through TRP channel modulation
par: Obulapathi Ummadisetty, et autres
Publié: (2026)

First‐in‐human assessment of safety and pharmacokinetics of EP9001A:an anti‐nerve growth factor antibody for chronic pain treatment
par: Yue Cheng, et autres
Publié: (2025)

External validation of a therapeutic window for risperidone in children with autism spectrum disorder
par: Rebecca A. Hermans, et autres
Publié: (2025)

Caspase Recruitment Domain 6 ( CARD6) is the therapeutic target of dihydroartemisinin for lupus nephritis based on Proteolysis Targeting Chimera (PROTAC) technology
par: Honglian Li, et autres
Publié: (2026)

FM‐dye inhibition of Piezo2 relieves mechanically evoked pain in mouse models of acute inflammatory and osteoarthritic knee pain
par: Natalie S. Adamczyk, et autres
Publié: (2026)

From taboo to treatment: The emergence of psychedelics in the management of pain and opioid use disorder
par: Jeremy Weleff, et autres
Publié: (2024)

Cannabinoid CB2 receptor‐mediated analgesia: mechanism‐based insights and therapeutic potential
par: Kelsey G. Guenther, et autres
Publié: (2025)

Chicoric acid exerts therapeutic effects in DSS‐induced ulcerative colitis by targeting the USP9X/IGF2BP2 axis
par: Wei Chen, et autres
Publié: (2024)

Inhibition of GRK2 mitigates cisplatin‐induced acute and chronic nephrotoxicity by targeting the NADPH oxidase 4/oxidative stress axis
par: Fei Duan, et autres
Publié: (2026)

Emerging therapeutic opportunities for psychedelic and related drugs
par: Susan Wonnacott, et autres
Publié: (2026)

Non‐canonical nitric oxide signalling and DNA methylation: Inflammation induced epigenetic alterations and potential drug targets
par: Christopher H. Switzer
Publié: (2024)

Mindfulness‐Oriented Recovery Enhancement: Implementing an evidence‐based intervention for chronic pain, opioid use, and opioid addiction in clinical settings
par: Eric L. Garland
Publié: (2024)

Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease
par: Muhammad Waqas Sadiq, et autres
Publié: (2024)

EDITORIAL for BJP themed issue “noncoding RNA therapeutics”
par: Yvan Devaux, et autres
Publié: (2024)

Role of monocarboxylate transporters in cancer immunology and their therapeutic potential
par: Ferdos Faghihkhorasani, et autres
Publié: (2025)

The relationship of pain intensity and opioid craving with delayed methadone dose: A preliminary study of individuals with opioid use disorder
par: R. Ross MacLean, et autres
Publié: (2024)

Schwann cell TRPA1 elicits reserpine‐induced fibromyalgia pain in mice
par: Evelyne Silva Brum, et autres
Publié: (2024)

Evaluation of the effect of CYP2D6 and OCT1 polymorphisms on the pharmacokinetics of tramadol: Implications for clinical safety and dose rationale in paediatric chronic pain
par: Paul Healy, et autres
Publié: (2024)

Have plastic culture models prevented the discovery of effective cancer therapeutics?
par: Kevin M. Tharp
Publié: (2024)

Spotlight commentary: Nitric oxide, vascular dysfunction and emerging therapeutic insights
par: Luciana Koren, et autres
Publié: (2025)

A novel role for microtubule affinity‐regulating kinases in neuropathic pain
par: Yao‐Qin Shi, et autres
Publié: (2024)